Tiltan Pharma

Tiltan Pharma is a forward-thinking biotechnology company based in Jerusalem, focused on pioneering innovative cancer treatments. Located at 2-4 Hi-tech Village, Edmond Safra Campus Givat Ram, P.O.B. 39026, Jerusalem, Jerusalem District 91390, IL, Tiltan Pharma is dedicated to developing novel and synergistic drug combinations to combat cancer effectively. Tiltan Pharma aims to transform therapeutic approaches through multi-faceted interventions, combining agents that target different mechanisms of action.

The company's leading product, TL-118, showcases Tiltan Pharma's commitment to innovation by combining generic drugs with anti-angiogenic and immune modulation properties. TL-118 uniquely repurposes drugs with complementary mechanisms, administered in a specialized regimen, demonstrating safety and efficacy across various tumors.

Tiltan Pharma continues to advance clinical trials, evaluating TL-118's safety and efficacy in combination with standard care for metastatic pancreatic cancer. Tiltan Pharma's strategic approach ensures a fast regulatory pathway and strong patent protection, emphasizing its commitment to delivering groundbreaking cancer treatments. We invite the manager of Tiltan Pharma to create a customized and exclusive company showcase and product listing on our platform.